Terms: = Lung cancer AND CNBP, P62633, 7555, ENSG00000169714, ZNF9, RNF163, DM2
6 results:
1. Metformin Has Positive Therapeutic Effects in Colon cancer and lung cancer.
Henderson D; Frieson D; Zuber J; Solomon SS
Am J Med Sci; 2017 Sep; 354(3):246-251. PubMed ID: 28918830
[TBL] [Abstract] [Full Text] [Related]
2. Synergistic effects of metformin in combination with EGFR-TKI in the treatment of patients with advanced non-small cell lung cancer and type 2 diabetes.
Chen H; Yao W; Chu Q; Han R; Wang Y; Sun J; Wang D; Wang Y; Cao M; He Y
Cancer Lett; 2015 Dec; 369(1):97-102. PubMed ID: 26341687
[TBL] [Abstract] [Full Text] [Related]
3. cancer detection rates following enrolment in a disease management programme for type 2 diabetes.
Geier AS; Wellmann J; Wellmann I; Kajüter H; Heidinger O; Hempel G; Hense HW
Diabetologia; 2013 Sep; 56(9):1944-8. PubMed ID: 23722623
[TBL] [Abstract] [Full Text] [Related]
4. Risk factors for idiopathic pulmonary fibrosis in a Mexican population. A case-control study.
García-Sancho Figueroa MC; Carrillo G; Pérez-Padilla R; Fernández-Plata MR; Buendía-Roldán I; Vargas MH; Selman M
Respir Med; 2010 Feb; 104(2):305-9. PubMed ID: 19782552
[TBL] [Abstract] [Full Text] [Related]
5. Should mediastinoscopy actually be incorporated into the FDG PET strategy for patients with non-small cell lung carcinoma?
Hayashi K; Abe K; Yano F; Watanabe S; Iwasaki Y; Kosuda S
Ann Nucl Med; 2005 Jul; 19(5):393-8. PubMed ID: 16164196
[TBL] [Abstract] [Full Text] [Related]
6. Low-dose oral glyburide reduces glucose production rates in patients with impaired fasting glucose.
Bavirti S; Tayek JA
Metabolism; 2003 Apr; 52(4):407-12. PubMed ID: 12701050
[TBL] [Abstract] [Full Text] [Related]
